This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
type diabetes | 868 |
diabetes mellitus | 476 |
insulin resistance | 330 |
metabolic syndrome | 315 |
risk factors | 247 |
blood glucose | 241 |
blood pressure | 201 |
diabetic patients | 187 |
glycemic control | 174 |
physical activity | 148 |
mg dl | 125 |
adipose tissue | 123 |
risk factor | 120 |
oxidative stress | 113 |
glucose tolerance | 110 |
health care | 109 |
glucose levels | 106 |
body mass | 104 |
increased risk | 102 |
coronavirus disease | 100 |
significantly higher | 100 |
fatty liver | 99 |
diabetes care | 99 |
cardiovascular risk | 97 |
systematic review | 96 |
waist circumference | 95 |
without diabetes | 93 |
body weight | 91 |
liver disease | 90 |
cardiovascular disease | 89 |
insulin sensitivity | 87 |
mass index | 86 |
public health | 84 |
control group | 76 |
plasma glucose | 73 |
glucose control | 72 |
diabetes self | 70 |
fasting glucose | 69 |
weight loss | 68 |
lipid profile | 67 |
impaired glucose | 66 |
higher risk | 65 |
mean age | 63 |
cohort study | 60 |
dm patients | 60 |
novel coronavirus | 60 |
two groups | 60 |
acute respiratory | 59 |
diabetic foot | 58 |
present study | 58 |
glucose monitoring | 58 |
among patients | 58 |
type diabetic | 57 |
converting enzyme | 57 |
glycaemic control | 56 |
glucose metabolism | 56 |
diabetes management | 55 |
fasting blood | 54 |
respiratory syndrome | 53 |
clinical characteristics | 52 |
uric acid | 51 |
latin america | 51 |
total cholesterol | 50 |
statistically significant | 49 |
weight gain | 49 |
sectional study | 47 |
cord uid | 46 |
insulin secretion | 46 |
doc id | 46 |
ng ml | 46 |
education program | 43 |
myocardial infarction | 43 |
heart failure | 43 |
immune response | 43 |
high prevalence | 42 |
high risk | 42 |
foot ulcers | 42 |
obese patients | 41 |
years old | 41 |
chronic diseases | 41 |
density lipoprotein | 40 |
significant differences | 40 |
fat diet | 39 |
tolerance test | 39 |
severe acute | 39 |
cardiovascular diseases | 39 |
world health | 38 |
alcoholic fatty | 38 |
chronic disease | 38 |
endothelial dysfunction | 38 |
controlled trial | 37 |
positive correlation | 37 |
fasting plasma | 37 |
mg kg | 37 |
obese subjects | 37 |
among people | 37 |
intensive care | 36 |
reactive protein | 36 |
abdominal obesity | 36 |
syndrome coronavirus | 36 |
older adults | 36 |
mental health | 35 |
clinical practice | 35 |
serum levels | 35 |
artery disease | 35 |
health organization | 35 |
significantly lower | 35 |
diabetes education | 35 |
clinical trial | 35 |
newly diagnosed | 34 |
general population | 34 |
regression analysis | 34 |
fatty acids | 34 |
diabetes distress | 34 |
kidney disease | 33 |
hospitalized patients | 33 |
coronary artery | 33 |
bariatric surgery | 33 |
high levels | 33 |
oral glucose | 33 |
nonalcoholic fatty | 33 |
logistic regression | 32 |
diagnosed diabetes | 32 |
continuous glucose | 32 |
body fat | 32 |
clinical outcomes | 32 |
metabolic control | 32 |
immune system | 31 |
significant reduction | 31 |
gene expression | 31 |
cardiometabolic risk | 31 |
significant difference | 31 |
diabetes association | 31 |
diabetic subjects | 31 |
primary care | 30 |
international diabetes | 30 |
ae years | 30 |
skeletal muscle | 30 |
randomized controlled | 30 |
diabetes patients | 30 |
gestational diabetes | 30 |
diastolic blood | 29 |
cardiovascular events | 29 |
national health | 29 |
diabetes prevalence | 29 |
patients without | 29 |
social support | 29 |
inflammatory cytokines | 29 |
foot temperature | 29 |
direct cost | 28 |
diabetic retinopathy | 28 |
significantly increased | 28 |
mg day | 28 |
receptor blockers | 28 |
clinical course | 28 |
diabetes among | 27 |
diabetes federation | 27 |
food intake | 27 |
physical inactivity | 27 |
glucose level | 27 |
higher prevalence | 27 |
heart disease | 27 |
endothelial cells | 27 |
hepatic insulin | 26 |
insulin levels | 26 |
plasma levels | 26 |
high glucose | 26 |
critically ill | 26 |
odds ratio | 26 |
national diabetes | 26 |
ace inhibitors | 26 |
factors associated | 26 |
united states | 26 |
chronic kidney | 26 |
people living | 26 |
income countries | 25 |
respiratory distress | 25 |
significantly reduced | 25 |
angiotensin converting | 25 |
south texas | 25 |
metabolic risk | 25 |
primary outcome | 25 |
middle east | 25 |
least one | 24 |
american diabetes | 24 |
beneficial effects | 24 |
clinical trials | 24 |
hepatic steatosis | 24 |
per day | 24 |
significant increase | 24 |
high fat | 24 |
obese women | 24 |
diabetes type | 24 |
diabetic rats | 24 |
significantly associated | 24 |
plasma leptin | 24 |
patients infected | 24 |
systolic blood | 23 |
impaired fasting | 23 |
poor prognosis | 23 |
visceral fat | 23 |
nitric oxide | 23 |
previous studies | 23 |
glucose homeostasis | 23 |
ae vs | 23 |
morbidly obese | 23 |
diabetes prevention | 23 |
clinical features | 23 |
central obesity | 23 |
care unit | 23 |
university hospital | 22 |
indirect cost | 22 |
nonalcoholic steatohepatitis | 22 |
icu admission | 22 |
medical care | 22 |
primary composite | 22 |
significant decrease | 22 |
fat mass | 22 |
pg ml | 22 |
economic burden | 22 |
composite outcome | 22 |
disease severity | 21 |
temperature monitoring | 21 |
undiagnosed diabetes | 21 |
informed consent | 21 |
distress syndrome | 21 |
elevated levels | 21 |
family history | 21 |
insulin therapy | 21 |
important role | 21 |
like peptide | 21 |
angiotensin receptor | 21 |
infectious diseases | 20 |
hypertensive patients | 20 |
retrospective cohort | 20 |
cardiometabolic multimorbidity | 20 |
leptin levels | 20 |
foot ulcer | 20 |
cell function | 20 |
serum leptin | 20 |
lipoprotein cholesterol | 20 |
second biennium | 20 |
month follow | 20 |
hdl cholesterol | 20 |
severe covid | 20 |
control study | 20 |
ill patients | 20 |
body composition | 20 |
obese children | 20 |
one hundred | 19 |
study showed | 19 |
health outcomes | 19 |
observational study | 19 |
east respiratory | 19 |
blood samples | 19 |
standard deviation | 19 |
increased susceptibility | 19 |
health systems | 19 |
inflammatory markers | 19 |
model assessment | 19 |
healthy individuals | 19 |
health status | 19 |
diabetes control | 19 |
chronic inflammation | 18 |
controlled trials | 18 |
angiotensin ii | 18 |
fatty acid | 18 |
viral infections | 18 |
normal weight | 18 |
gastric bypass | 18 |
mmol mol | 18 |
normal glucose | 18 |
diabetic mice | 18 |
pilot study | 18 |
fasting insulin | 18 |
authors declare | 18 |
disease worsening | 18 |
mrna expression | 18 |
diabetic complications | 18 |
liver fat | 18 |
results suggest | 18 |
postmenopausal women | 18 |
type ii | 18 |
study included | 18 |
linear regression | 18 |
confidence interval | 18 |
severe disease | 18 |
study group | 18 |
overweight obese | 18 |
diabetic nephropathy | 17 |
liver fibrosis | 17 |
adiponectin levels | 17 |
gut microbiota | 17 |
health system | 17 |
diabetes complications | 17 |
related complications | 17 |
serum insulin | 17 |
retrospective study | 17 |
diabetic individuals | 17 |
blood sugar | 17 |
diabetes online | 17 |
communicable diseases | 17 |
value co | 17 |
enzyme inhibitors | 17 |
also found | 17 |
sample size | 17 |
patients hospitalized | 17 |
higher levels | 17 |
arterial hypertension | 17 |
first biennium | 17 |
pancreatic beta | 16 |
beta cell | 16 |
metabolic abnormalities | 16 |
regression models | 16 |
significantly decreased | 16 |
advanced glycation | 16 |
global burden | 16 |
positively correlated | 16 |
fetal growth | 16 |
family members | 16 |
based study | 16 |
current study | 16 |
glycated hemoglobin | 16 |
insulin signaling | 16 |
higher mortality | 16 |
online communities | 16 |
social distancing | 16 |
ace expression | 16 |
animal models | 16 |
mean ae | 16 |
alcohol consumption | 16 |
fat content | 16 |
alcoholic steatohepatitis | 16 |
obese individuals | 16 |
per annum | 16 |
significantly different | 16 |
data collection | 16 |
negative correlation | 16 |
glycemic variability | 16 |
prospective study | 16 |
medical records | 16 |
among participants | 16 |
high blood | 16 |
age group | 16 |
beta cells | 16 |
lipid metabolism | 16 |
aldosterone system | 15 |
tract infections | 15 |
molecular mechanisms | 15 |
virus infection | 15 |
onset diabetes | 15 |
significant positive | 15 |
without ms | 15 |
greater risk | 15 |
known diabetes | 15 |
healthy subjects | 15 |
healthy south | 15 |
low hdl | 15 |
metabolic disorders | 15 |
without metabolic | 15 |
disease control | 15 |
remote monitoring | 15 |
infected patients | 15 |
mouse model | 15 |
healthcare providers | 15 |
health insurance | 15 |
lower levels | 15 |
included patients | 15 |
type dm | 15 |
homeostasis model | 15 |
insulin infusion | 15 |
social media | 15 |
study shows | 15 |
energy expenditure | 15 |
immune responses | 15 |
clinical data | 14 |
continuous variables | 14 |
mechanical ventilation | 14 |
digital health | 14 |
regression model | 14 |
chronic conditions | 14 |
systemic inflammation | 14 |
qualitative study | 14 |
internal medicine | 14 |
cell apoptosis | 14 |
cross sectional | 14 |
diabetes risk | 14 |
among women | 14 |
insulin pump | 14 |
long term | 14 |
significant correlation | 14 |
independent predictors | 14 |
health problem | 14 |
heart rate | 14 |
hip ratio | 14 |
insulin resistant | 14 |
healthcare professionals | 14 |
lipid accumulation | 14 |
older age | 14 |
health professionals | 14 |
average glucose | 14 |
sars coronavirus | 14 |
health services | 14 |
innate immune | 14 |
intervention group | 14 |
increased prevalence | 14 |
primary prevention | 14 |
plantar pressures | 14 |
diabetes group | 14 |
signaling pathway | 14 |
young adults | 14 |
covid pandemic | 14 |
worse prognosis | 14 |
glucose concentration | 14 |
blood sample | 14 |
home foot | 13 |
mellitus patients | 13 |
results showed | 13 |
age groups | 13 |
across latam | 13 |
diabetes treatment | 13 |
several studies | 13 |
cardiovascular outcomes | 13 |
vo max | 13 |
diabetes may | 13 |
healthy controls | 13 |
controlled diabetes | 13 |
vascular complications | 13 |
glycation end | 13 |
pancreatic islets | 13 |
pa level | 13 |
existing diabetes | 13 |
induced insulin | 13 |
insulin treatment | 13 |
mortality due | 13 |
data collected | 13 |
curcumin supplementation | 13 |
protein kinase | 13 |
life expectancy | 13 |
low density | 13 |
lung injury | 13 |
measured using | 13 |
visceral adipose | 13 |
patients compared | 13 |
ae sd | 13 |
latin american | 13 |
disease risk | 13 |
mortality rate | 13 |
biochemical parameters | 13 |
free fatty | 13 |
health promotion | 13 |
recent study | 13 |
diabetic ketoacidosis | 13 |
poor glycemic | 13 |
overweight obesity | 13 |
nutritional status | 13 |
fat percentage | 13 |
wistar rats | 13 |
lg ml | 13 |
million people | 13 |
glucose variability | 13 |
diagnostic criteria | 13 |
low levels | 13 |
dependent diabetes | 13 |
health expenditure | 12 |
emotional support | 12 |
relative risk | 12 |
confirmed cases | 12 |
early detection | 12 |
polycystic ovary | 12 |
socioeconomic status | 12 |
serum uric | 12 |
average age | 12 |
clinical studies | 12 |
end products | 12 |
care setting | 12 |
data suggest | 12 |
significant association | 12 |
cytokine storm | 12 |
even though | 12 |
viral infection | 12 |
studies reported | 12 |
care services | 12 |
insulin delivery | 12 |
subjects without | 12 |
independent risk | 12 |
ml min | 12 |
inclusion criteria | 12 |
mainly due | 12 |
energy metabolism | 12 |
women aged | 12 |
arterial stiffness | 12 |
four groups | 12 |
disease progression | 12 |
staphylococcus aureus | 12 |
adverse outcomes | 12 |
research design | 12 |
oxygen species | 12 |
respiratory tract | 12 |
cardiovascular mortality | 12 |
macrovascular complications | 12 |
developing diabetes | 12 |
confidence intervals | 12 |
angiotensin system | 12 |
reactive oxygen | 12 |
three groups | 12 |
genes involved | 12 |
diabetes compared | 12 |
outpatient clinic | 12 |
endoplasmic reticulum | 12 |
animal model | 12 |
rights reserved | 12 |
serum adiponectin | 12 |
sars cov | 12 |
worse outcomes | 12 |
predictive value | 12 |
randomised controlled | 12 |
new coronavirus | 11 |
elderly patients | 11 |
median age | 11 |
glucose tolerant | 11 |
independent predictor | 11 |
worries related | 11 |
stem cells | 11 |
may also | 11 |
care systems | 11 |
management among | 11 |
pregnant women | 11 |
epithelial cells | 11 |
pulmonary disease | 11 |
homa index | 11 |
amino acids | 11 |
non diabetic | 11 |
increasing prevalence | 11 |
sugar handshake | 11 |
important factor | 11 |
ae mg | 11 |
glucose uptake | 11 |
clinical presentation | 11 |
innate immunity | 11 |
physically active | 11 |
fasting serum | 11 |
groups according | 11 |
study design | 11 |
inflammatory response | 11 |
developing countries | 11 |
aged years | 11 |
ii diabetes | 11 |
cov period | 11 |
diabetes selfmanagement | 11 |
good health | 11 |
isolation sites | 11 |
per se | 11 |
high level | 11 |
health workers | 11 |
healthcare services | 11 |
leisure time | 11 |
organ damage | 11 |
categorical variables | 11 |
metabolic diseases | 11 |
randomized clinical | 11 |
cell mass | 11 |
rat model | 11 |
coronary angiography | 11 |
flash glucose | 11 |
dependent manner | 11 |
another study | 11 |
significant improvement | 11 |
microvascular complications | 11 |
study population | 11 |
care system | 11 |
interquartile range | 11 |
management education | 11 |
creatinine ratio | 11 |
diabetic population | 11 |
albumin creatinine | 11 |
study protocol | 11 |
western blot | 11 |
coronavirus infection | 11 |
energy intake | 10 |
acting insulin | 10 |
statistical analyses | 10 |
multiple regression | 10 |
triglyceride levels | 10 |
admission hyperglycemia | 10 |
kg day | 10 |
poor outcomes | 10 |
good glycemic | 10 |
clin pract | 10 |
uncontrolled diabetes | 10 |
diabetic medications | 10 |
study diabetes | 10 |
people without | 10 |
peripheral neuropathy | 10 |
increasing age | 10 |
mortality risk | 10 |
significantly improved | 10 |
diabetes status | 10 |
dipeptidyl peptidase | 10 |
res clin | 10 |
transcription factors | 10 |
rehabilitation program | 10 |
humoral immunity | 10 |
practical recommendations | 10 |
cardiovascular system | 10 |
inflammatory effects | 10 |
large number | 10 |
birth weight | 10 |
optimal glycemic | 10 |
pract doi | 10 |
mechanisms underlying | 10 |
lipid profiles | 10 |
th percentile | 10 |
confirmed covid | 10 |
weight reduction | 10 |
recent studies | 10 |
disease self | 10 |
left ventricular | 10 |
secondary outcomes | 10 |
ovary syndrome | 10 |
transcription factor | 10 |
tertiary care | 10 |
medical history | 10 |
visceral adiposity | 10 |
diabetes population | 10 |
bmi kg | 10 |
liver steatosis | 10 |
diabetes res | 10 |
side effects | 10 |
anthropometric measurements | 10 |
fatality rate | 10 |
european countries | 10 |
physical exercise | 10 |
lifestyle changes | 10 |
increased mortality | 10 |
treatment strategies | 10 |
leading cause | 10 |
six weeks | 10 |
multivariate analysis | 10 |
wound healing | 10 |
ae kg | 10 |
glycosylated hemoglobin | 10 |
foot care | 10 |
also observed | 10 |
diabetes screening | 10 |
risk group | 10 |
coronary heart | 10 |
showed increased | 10 |
subcutaneous adipose | 10 |
times higher | 10 |
cholesterol levels | 10 |
time pcr | 10 |
control subjects | 10 |
study aims | 10 |
remains unclear | 10 |
medical supplies | 10 |
total direct | 10 |
urinary tract | 10 |
blood flow | 10 |
group received | 10 |
major risk | 10 |
diabetic patient | 10 |
mitochondrial dysfunction | 10 |
mobile phone | 10 |
urotensin ii | 10 |
poorly controlled | 10 |
may lead | 10 |
crucial role | 10 |
severe clinical | 10 |
will also | 10 |
hcq use | 10 |
diabetes duration | 10 |
cell dysfunction | 10 |
ii receptor | 10 |
anthropometric data | 10 |
young children | 10 |
muscle cells | 10 |
diabetes community | 10 |
antihypertensive drugs | 10 |
serum creatinine | 10 |
randomly selected | 10 |
diabetes communities | 10 |
puerto rico | 10 |
chinese center | 10 |
clinical considerations | 10 |
insulin level | 10 |
results indicate | 10 |
atp iii | 10 |
global pandemic | 10 |
acute myocardial | 9 |
renal function | 9 |
chronic illness | 9 |
accepted article | 9 |
peripheral artery | 9 |
family medicine | 9 |
baseline characteristics | 9 |
hazard ratio | 9 |
published maps | 9 |
may reduce | 9 |
negative emotions | 9 |
disease management | 9 |
czech republic | 9 |
receptor agonists | 9 |
diagnosed type | 9 |
mortality among | 9 |
liver enzymes | 9 |
parental care | 9 |
may contribute | 9 |
capillary blood | 9 |
immune cells | 9 |
resistance training | 9 |
superoxide dismutase | 9 |
protective effects | 9 |
outcomes among | 9 |
complications associated | 9 |
protein expression | 9 |
endothelial function | 9 |
countries show | 9 |
des typ | 9 |
diabetes epidemic | 9 |
reduced insulin | 9 |
pon activity | 9 |
positively associated | 9 |
lifestyle intervention | 9 |
among subjects | 9 |
among older | 9 |
springer nature | 9 |
hong kong | 9 |
insulin production | 9 |
cancer risk | 9 |
treatment outcomes | 9 |
diabetes plan | 9 |
square test | 9 |
older people | 9 |
existing type | 9 |
mean body | 9 |
mycobacterium tuberculosis | 9 |
examination survey | 9 |
anthropometric measures | 9 |
related foot | 9 |
beneficial effect | 9 |
consecutive patients | 9 |
study conducted | 9 |
liver diseases | 9 |
gut microbiome | 9 |
pressure measurements | 9 |
subsequent follow | 9 |
cytokine production | 9 |
nature remains | 9 |
investigated whether | 9 |
missing data | 9 |
calorie diet | 9 |
renal disease | 9 |
manage diabetes | 9 |
glucose intolerance | 9 |
immune dysfunction | 9 |
plasma insulin | 9 |
tandem basal | 9 |
control among | 9 |
ace receptor | 9 |
multiple linear | 9 |
study involved | 9 |
pulmonary tuberculosis | 9 |
health conditions | 9 |
global health | 9 |
determine whether | 9 |
diabetes research | 9 |
results show | 9 |
disease prevention | 9 |
insulin action | 9 |
disease patients | 9 |
usual care | 9 |
basal iq | 9 |
among persons | 9 |
group showed | 9 |
studies showed | 9 |
among adults | 9 |
continued working | 9 |
homocysteine levels | 9 |
hfd myr | 9 |
findings suggest | 9 |
unclear whether | 9 |
discharged alive | 9 |
pao fio | 9 |
hypoglycemic episodes | 9 |
height ratio | 9 |
diabetes diabetes | 9 |
jurisdictional claims | 9 |
medical treatment | 9 |
case series | 9 |
severely obese | 9 |
patients treated | 9 |
remains neutral | 9 |
significantly elevated | 9 |
study period | 9 |
plantar pressure | 9 |
gene polymorphism | 9 |
regarding diabetes | 9 |
lymphoid cells | 9 |
key role | 9 |
coronavirus infections | 9 |
endothelial cell | 9 |
multivariate logistic | 9 |
innate lymphoid | 9 |
growth factor | 9 |
individuals without | 9 |
well known | 9 |
poor glycaemic | 9 |
education programs | 9 |
glucose concentrations | 9 |
may result | 9 |
health problems | 9 |
cardiovascular complications | 9 |
institutional affiliations | 9 |
pump therapy | 9 |
dawley rats | 8 |
advanced fibrosis | 8 |
new york | 8 |
healthy control | 8 |
three patients | 8 |
west zone | 8 |
mortality rates | 8 |
resistin gene | 8 |
data analysis | 8 |
lifestyle modification | 8 |
chest pain | 8 |
china covid | 8 |
people infected | 8 |
normal body | 8 |
obese group | 8 |
less likely | 8 |
hypoglycemic agents | 8 |
islet amyloid | 8 |
peripheral arterial | 8 |
hospital admission | 8 |
adjusted odds | 8 |
sao paulo | 8 |
central america | 8 |
diabetic cardiomyopathy | 8 |
independent variables | 8 |
adverse effects | 8 |
elevated serum | 8 |
individual household | 8 |
texas initiative | 8 |
increased serum | 8 |
hypoglycaemic attacks | 8 |
food consumption | 8 |
muscle mass | 8 |
participants will | 8 |
note springer | 8 |
noncommunicable diseases | 8 |
higher among | 8 |
common infections | 8 |
nk cells | 8 |
lps concentrations | 8 |
obese mice | 8 |
important lessons | 8 |
literature review | 8 |
bmi ae | 8 |
patients undergoing | 8 |
longitudinal study | 8 |
platelet activation | 8 |
therapeutic implications | 8 |
management behaviors | 8 |
adult inpatients | 8 |
data show | 8 |
pregnant mice | 8 |
direct correlation | 8 |
diabetes increases | 8 |
nervous system | 8 |
creative commons | 8 |
may cause | 8 |
diabetes atlas | 8 |
glycemic levels | 8 |
one study | 8 |
considered statistically | 8 |
reported health | 8 |
coronavirus pneumonia | 8 |
care needs | 8 |
eating habits | 8 |
evidence suggests | 8 |
descriptive study | 8 |
metabolic profile | 8 |
significantly correlated | 8 |
defined based | 8 |
mean hba | 8 |
without dm | 8 |
care professionals | 8 |
first week | 8 |
tissue inflammation | 8 |
will increase | 8 |
pandemic influenza | 8 |
necrosis factor | 8 |
lipid peroxidation | 8 |
mean value | 8 |
thematic analysis | 8 |
diabetes metab | 8 |
overweight patients | 8 |
prospective cohort | 8 |
research group | 8 |
increased expression | 8 |
cholesterol level | 8 |
chronic obstructive | 8 |
significant cad | 8 |
diabetes hospitalized | 8 |
cell death | 8 |
tight glycemic | 8 |
respiratory disease | 8 |
glucose regulation | 8 |
serum glucose | 8 |
higher incidence | 8 |
life style | 8 |
month period | 8 |
community health | 8 |
signaling pathways | 8 |
one patient | 8 |
insulin dose | 8 |
obstructive pulmonary | 8 |
adaptive immunity | 8 |
protective role | 8 |
systematic reviews | 8 |
bacterial infections | 8 |
based cohort | 8 |
also reported | 8 |
nutrition examination | 8 |
visceral obesity | 8 |
environmental factors | 8 |
adverse outcome | 8 |
grade inflammation | 8 |
negative impact | 8 |
higher percentage | 8 |
increased levels | 8 |
rheumatic diseases | 8 |
peer support | 8 |
depressive symptoms | 8 |
fasting state | 8 |
data showed | 8 |
insulin receptor | 8 |
united kingdom | 8 |
qt interval | 8 |
patients underwent | 8 |
different types | 8 |
among individuals | 8 |
microvascular disease | 8 |
reviewed articles | 8 |
improve health | 8 |
random blood | 8 |
may increase | 8 |
lessons learned | 8 |
median direct | 7 |
antidiabetic antihypertensive | 7 |
glycogen synthase | 7 |
male gender | 7 |
cell proliferation | 7 |
higher rate | 7 |
group treated | 7 |
diabetic neuropathy | 7 |
fat distribution | 7 |
observational studies | 7 |
severe cases | 7 |
nash patients | 7 |
currently available | 7 |
pressure monitoring | 7 |
supplementary material | 7 |
amyloid polypeptide | 7 |
important risk | 7 |
acute kidney | 7 |
including diabetes | 7 |
cd cd | 7 |
total costs | 7 |
fetal macrosomia | 7 |
analysis revealed | 7 |
analysis showed | 7 |
leptin level | 7 |
consensus statement | 7 |
receptor agonist | 7 |
two hundred | 7 |
footwear adherence | 7 |
analyzed using | 7 |
fold higher | 7 |
apparently healthy | 7 |
burkholderia pseudomallei | 7 |
kg body | 7 |
risk patients | 7 |
worse covid | 7 |
hepatocellular carcinoma | 7 |
glomerular filtration | 7 |
clarified criteria | 7 |
relative muscle | 7 |
study will | 7 |
showed significantly | 7 |
remaining studies | 7 |
monitoring system | 7 |
defined according | 7 |
albumin excretion | 7 |
virtual care | 7 |
metabolic disturbances | 7 |
inflammatory status | 7 |
odds ratios | 7 |
patients may | 7 |
system inhibitors | 7 |
increased blood | 7 |
performed using | 7 |
cad patients | 7 |
diabetes therapy | 7 |
natural killer | 7 |
essential role | 7 |
controlled clinical | 7 |
among obese | 7 |
anthropometric parameters | 7 |
general hospital | 7 |
general practitioners | 7 |
patients affected | 7 |
angiotensin i | 7 |
medication adherence | 7 |
multiple daily | 7 |
ethnic groups | 7 |
associated factors | 7 |
caloric intake | 7 |
increase ace | 7 |
previous glycemic | 7 |
virus disease | 7 |
risk reduction | 7 |
commercially available | 7 |
laboratory findings | 7 |
management program | 7 |
antioxidant capacity | 7 |
will require | 7 |
careful evaluation | 7 |
hepatic glucose | 7 |
randomly divided | 7 |
proinflammatory cytokines | 7 |
national cholesterol | 7 |
ischemic heart | 7 |
group ii | 7 |
mets components | 7 |
severe hypoglycemia | 7 |
serious complications | 7 |
aged ae | 7 |
will help | 7 |
hospital death | 7 |
glucose management | 7 |
systolic bp | 7 |
two pandemics | 7 |
mets patients | 7 |
least two | 7 |
curcumin treatment | 7 |
widely used | 7 |
study clinical | 7 |
cov infection | 7 |
severe dengue | 7 |
overall prevalence | 7 |
media thickness | 7 |
total cost | 7 |
severe hypoglycemic | 7 |
physical activities | 7 |
diabetic group | 7 |
isolation site | 7 |
hay fever | 7 |
developing country | 7 |
well established | 7 |
real time | 7 |
kg min | 7 |
showed higher | 7 |
american countries | 7 |
cox proportional | 7 |
polymerase chain | 7 |
female patient | 7 |
glucose cotransporter | 7 |
healthy lifestyle | 7 |
two patients | 7 |
sglt i | 7 |
diabetes development | 7 |
proliferative diabetic | 7 |
excess body | 7 |
thyroid function | 7 |
empowerment theory | 7 |
total body | 7 |
first years | 7 |
dietary intake | 7 |
may need | 7 |
mellitus type | 7 |
mean bmi | 7 |
school children | 7 |
ace receptors | 7 |
rheumatoid arthritis | 7 |
determined using | 7 |
host cells | 7 |
potential therapeutic | 7 |
group education | 7 |
assessed using | 7 |
arterial disease | 7 |
studies included | 7 |
diabetes people | 7 |
dpp inhibitors | 7 |
high cardiovascular | 7 |
system blockers | 7 |
chain reaction | 7 |
stopped working | 7 |
medical management | 7 |
age matched | 7 |
regular physical | 7 |
among type | 7 |
routine care | 7 |
diabetes knowledge | 7 |
may predispose | 7 |
total number | 7 |
influenza virus | 7 |
mellitus diabetes | 7 |
hubei province | 7 |
mild symptoms | 7 |
behavioral beliefs | 7 |
will receive | 7 |
highly prevalent | 7 |
cause mortality | 7 |
high school | 7 |
normal diet | 7 |
future studies | 7 |
pressure monitor | 7 |
group without | 7 |
diabetic status | 7 |
double burden | 7 |
metabolic parameters | 7 |
significant negative | 7 |
filtration rate | 7 |
insulin clearance | 7 |
electronic medical | 7 |
national surveys | 7 |
healthy volunteers | 7 |
higher bmi | 7 |
liver injury | 7 |
reduced hdl | 7 |
national quarantine | 7 |
future research | 7 |
medical conditions | 7 |
improve diabetes | 7 |
frequently observed | 7 |
patient education | 7 |
cutoff value | 7 |
cholesterol education | 7 |
position statement | 7 |
decreased expression | 7 |
adhesion molecules | 7 |
higher body | 7 |
care model | 7 |
primary health | 7 |
correlated negatively | 7 |
rapid acting | 7 |
higher level | 7 |
normal blood | 7 |
higher rates | 7 |
mesenchymal stem | 7 |
ferritin levels | 7 |
rural guatemala | 7 |
cvd risk | 7 |
health disparities | 7 |
infectious disease | 7 |
insulin injections | 7 |
associated complications | 7 |
policy makers | 7 |
laboratory tests | 7 |
contracting covid | 7 |
better manage | 7 |
term effects | 7 |
insulin dependent | 7 |
iu day | 7 |
north india | 7 |
specific worries | 7 |
randomized trial | 7 |
southern india | 7 |
diastolic pressure | 7 |
basal insulin | 7 |
adult population | 7 |
study aimed | 7 |
high density | 7 |
cardiometabolic disorders | 7 |
respiratory infections | 7 |
diabetes covid | 7 |
negatively correlated | 7 |
might play | 7 |
islet inflammation | 7 |
hospital use | 7 |
irisin levels | 7 |
data available | 7 |
health centers | 6 |
controlled study | 6 |
device data | 6 |
acid reduction | 6 |
metabolic rate | 6 |
fed rats | 6 |
dm compared | 6 |
vascular endothelial | 6 |
fr da | 6 |
less frequently | 6 |
homeostasis alterations | 6 |
lockdown period | 6 |
lifestyle interventions | 6 |
peripheral tissues | 6 |
antioxidant status | 6 |
help patients | 6 |
strong association | 6 |
physically inactive | 6 |
glucosidase inhibitors | 6 |
male patients | 6 |
healthcare system | 6 |
severely ill | 6 |
cell activation | 6 |
studies show | 6 |
intensive insulin | 6 |
sometimes felt | 6 |
oral hypoglycemic | 6 |
activated protein | 6 |
women without | 6 |
based education | 6 |
case study | 6 |
variant allele | 6 |
developing type | 6 |
mortality trend | 6 |
italian government | 6 |
clinical management | 6 |
two different | 6 |
single cardiometabolic | 6 |
costa rica | 6 |
antiretroviral therapy | 6 |
available data | 6 |
diabetes registries | 6 |
strength training | 6 |
york city | 6 |
inflammatory responses | 6 |
bypass surgery | 6 |
vitro studies | 6 |
patients need | 6 |
tolerant offspring | 6 |
may improve | 6 |
recent meta | 6 |
developing cardiovascular | 6 |
previously reported | 6 |
medical sciences | 6 |
increased rates | 6 |
mm hg | 6 |
prothrombin time | 6 |
obesity may | 6 |
digital glucometer | 6 |
diabetes trends | 6 |
plasma level | 6 |
patienten innen | 6 |
increased odds | 6 |
study investigated | 6 |
china clinical | 6 |
rapid assessment | 6 |
laboratory parameters | 6 |
correlated positively | 6 |
elevated risk | 6 |
without nafld | 6 |
patients presented | 6 |
excessive weight | 6 |
homa ir | 6 |
patients showed | 6 |
daily insulin | 6 |
improved insulin | 6 |
family support | 6 |
tumor necrosis | 6 |
organ failure | 6 |
metabolism disorders | 6 |
receiver operating | 6 |
inflammatory actions | 6 |
better understanding | 6 |
north zone | 6 |
poisson regression | 6 |
ir index | 6 |
aim framework | 6 |
silent myocardial | 6 |
foot disease | 6 |
surgical treatment | 6 |
genetic factors | 6 |
nationwide lockdown | 6 |
therapeutic targets | 6 |
increased significantly | 6 |
hospital mortality | 6 |
recent data | 6 |
blood cell | 6 |
national institute | 6 |
prevalence estimates | 6 |
last two | 6 |
radiological findings | 6 |
adults aged | 6 |
foam cells | 6 |
direct costs | 6 |
endurance exercise | 6 |
global epidemic | 6 |
cell line | 6 |
adults living | 6 |
many countries | 6 |
drug therapy | 6 |
baseline levels | 6 |
limited access | 6 |
collected data | 6 |
nationally representative | 6 |
patients vs | 6 |
brazilian population | 6 |
may explain | 6 |
showed significant | 6 |
soft tissue | 6 |
blood vessels | 6 |
autonomic neuropathy | 6 |
education level | 6 |
qualitative research | 6 |
higher blood | 6 |
cardiorespiratory fitness | 6 |
foot ulceration | 6 |
rd group | 6 |
control may | 6 |
argane oil | 6 |
higher values | 6 |
ad libitum | 6 |
total antioxidant | 6 |
four patients | 6 |
screening tool | 6 |
microrna expression | 6 |
related topics | 6 |
severe htgpos | 6 |
mitochondrial function | 6 |
vo peak | 6 |
care provided | 6 |
study participants | 6 |
serum lipid | 6 |
also included | 6 |
pressure control | 6 |
innen mit | 6 |
vascular disease | 6 |
urban area | 6 |
patients received | 6 |
one third | 6 |
probably due | 6 |
diabetes across | 6 |
analysed using | 6 |
east zone | 6 |
seriously ill | 6 |
patients attending | 6 |
population based | 6 |
clinic visits | 6 |
statistical significance | 6 |
medical university | 6 |
ulcer healing | 6 |
lifestyle factors | 6 |
household level | 6 |
brain natriuretic | 6 |
th cells | 6 |
adverse cardiovascular | 6 |
research study | 6 |
bone mineral | 6 |
lower respiratory | 6 |
pylori infection | 6 |
pwv time | 6 |
white blood | 6 |
fio ratio | 6 |
kidney injury | 6 |
diet containing | 6 |
obese diabetic | 6 |
obesity group | 6 |
ms components | 6 |
significantly greater | 6 |
care costs | 6 |
reticulum stress | 6 |
antioxidant enzymes | 6 |
ages accumulation | 6 |
interaction term | 6 |
incretin effect | 6 |
colorectal cancer | 6 |
apgar score | 6 |
mrna levels | 6 |
reduced liver | 6 |
viral replication | 6 |
respiratory failure | 6 |
year follow | 6 |
congestive heart | 6 |
last years | 6 |
highest risk | 6 |
prospective studies | 6 |
epidemiological studies | 6 |
risk score | 6 |
diabetes will | 6 |
related mortality | 6 |
peripheral insulin | 6 |
auditory insulin | 6 |
small number | 6 |
mice fed | 6 |
abdominal fat | 6 |
closely related | 6 |
metabolic disease | 6 |
diabetic children | 6 |
allow us | 6 |
statistical analysis | 6 |
ldl cholesterol | 6 |
serum ferritin | 6 |
secondary prevention | 6 |
major public | 6 |
population aged | 6 |
may play | 6 |
three hundred | 6 |
die ergebnisse | 6 |
among covid | 6 |
study using | 6 |
term complications | 6 |
prevalence rate | 6 |
matched controls | 6 |
psychosocial outcomes | 6 |
health issues | 6 |
reduced expression | 6 |
glutathione peroxidase | 6 |
insulin doses | 6 |
descriptive statistics | 6 |
dysmetabolic syndrome | 6 |
intima media | 6 |
patients receiving | 6 |
unknown diabetes | 6 |
significant higher | 6 |
inversely associated | 6 |
chronic hepatitis | 6 |
study suggests | 6 |
study provides | 6 |
progenitor cells | 6 |
cell count | 6 |
remained significant | 6 |
diabetes study | 6 |
commonly used | 6 |
towards empowering | 6 |
disease course | 6 |
binding protein | 6 |
diabetes outcomes | 6 |
written informed | 6 |
intracellular insulin | 6 |
insulin sensitive | 6 |
retention rates | 6 |
ejection fraction | 6 |
process evaluation | 6 |
million cases | 6 |
significant correlations | 6 |
glucose infusion | 6 |
optimal cut | 6 |
serum level | 6 |
early diagnosis | 6 |
elderly people | 6 |
improve clinical | 6 |
subjects aged | 6 |
chinese adults | 6 |
cell entry | 6 |
der kontrollgruppe | 6 |
age range | 6 |
tissue distribution | 6 |
health professional | 6 |
first time | 6 |
muscle insulin | 6 |
mean values | 6 |
dietary patterns | 6 |
fed mice | 6 |
peptide receptor | 6 |
induced diabetic | 6 |
chronic hyperglycaemia | 6 |
empowering diabetic | 6 |
acid level | 6 |
health emergency | 6 |
among diabetic | 6 |
dense ldl | 6 |
significant risk | 6 |
viral load | 6 |
age years | 6 |
arterial pressure | 6 |
costing items | 6 |
kidney failure | 6 |
new zealand | 6 |
possible role | 6 |
lower mortality | 6 |
atpiii criteria | 6 |
obese adults | 6 |
mit einer | 6 |
case report | 6 |
per patient | 6 |
outpatient clinics | 6 |
catecholamine secretion | 6 |
long duration | 6 |
will need | 6 |
adrenal medulla | 6 |
bei der | 6 |
glycated haemoglobin | 6 |
group i | 6 |
controlled patients | 6 |
univariate analysis | 6 |
cardiovascular morbidity | 5 |
insulin tolerance | 5 |
cancer survivors | 5 |
essential services | 5 |
fat oxidation | 5 |
annual direct | 5 |
health crisis | 5 |
metabolic alterations | 5 |
quarterly follow | 5 |
anthropometric markers | 5 |
alanine aminotransferase | 5 |
gestational weight | 5 |
patients admitted | 5 |
questions regarding | 5 |
resident macrophages | 5 |
poor weight | 5 |
scoping review | 5 |
therapeutic footwear | 5 |
gastrointestinal symptoms | 5 |
higher serum | 5 |
inflammatory rheumatic | 5 |
early stages | 5 |
defined obesity | 5 |
lean subjects | 5 |
female gender | 5 |
chronic low | 5 |
pro tag | 5 |
vascular function | 5 |
marital status | 5 |
saturated fat | 5 |
intravenous glucose | 5 |
without changes | 5 |
high insulin | 5 |
telehealth consultations | 5 |
decreased significantly | 5 |
current pandemic | 5 |
worse glucose | 5 |
infections among | 5 |
wuhan coronavirus | 5 |
high income | 5 |
psychological impact | 5 |
global diabetes | 5 |
average blood | 5 |
normal limits | 5 |
hispanic population | 5 |
participants experienced | 5 |
well recognized | 5 |
ige level | 5 |
preventing dfd | 5 |
health service | 5 |
increased fasting | 5 |
regional diabetes | 5 |
ada criteria | 5 |
getting infected | 5 |
presenting characteristics | 5 |
demographic characteristics | 5 |
value cocreation | 5 |
care activities | 5 |
economic status | 5 |
anthropometric characteristics | 5 |
lifestyle change | 5 |
health authorities | 5 |
health survey | 5 |
levels compared | 5 |
adverse events | 5 |
management behavior | 5 |
conditions among | 5 |
bmi cutoff | 5 |
significant reductions | 5 |
mellitus across | 5 |
blood lipids | 5 |
median indirect | 5 |
higher proportion | 5 |
inflammatory milieu | 5 |
spike glycoprotein | 5 |
improves glucose | 5 |
fasting hyperglycemia | 5 |
complement activation | 5 |
also known | 5 |
using multivariate | 5 |
proposed framework | 5 |
obese postmenopausal | 5 |
reddit diabetes | 5 |
genetic risk | 5 |
based diabetes | 5 |
diabetes worldwide | 5 |
multifaceted effects | 5 |
venous blood | 5 |
mehr als | 5 |
combination therapy | 5 |
potential solutions | 5 |
lean mass | 5 |
pivotal role | 5 |
inpatient diabetes | 5 |
oxidative damage | 5 |
frequent among | 5 |
fat area | 5 |
normal gt | 5 |
randomised trial | 5 |
prepregnancy weight | 5 |
elderly fld | 5 |
epidemiological data | 5 |
independently associated | 5 |
cardiovascular damage | 5 |
one year | 5 |
lu ml | 5 |
atrial fibrillation | 5 |
fasting glycaemia | 5 |
wellington towards | 5 |
commons attribution | 5 |
social isolation | 5 |
estimated glomerular | 5 |
related variables | 5 |
aceis arbs | 5 |
diabetes services | 5 |
indigenous population | 5 |
antibiotic therapy | 5 |
inhibitory activities | 5 |
mexican americans | 5 |
south india | 5 |
severe illness | 5 |
rats fed | 5 |
emerging evidence | 5 |
vegf gene | 5 |
glucose testing | 5 |
identified hypertension | 5 |
perceived crime | 5 |
cv risk | 5 |
cardiovascular outcome | 5 |
infection risk | 5 |
health concern | 5 |
decreased insulin | 5 |
increasing levels | 5 |
dio mice | 5 |
glucose production | 5 |
behavior changes | 5 |
online value | 5 |
corona virus | 5 |
glycemic status | 5 |
balanced diet | 5 |
costs associated | 5 |
kupffer cells | 5 |
transgenic expression | 5 |
study aim | 5 |
sedentary behavior | 5 |
exclusion criteria | 5 |
interferon gamma | 5 |
snp rs | 5 |
normal bmi | 5 |
chinese population | 5 |
ifg prevalence | 5 |
diabetes admitted | 5 |
term prognosis | 5 |
free mass | 5 |
comprehensive review | 5 |
psychosocial health | 5 |
skin temperature | 5 |
frequent monitoring | 5 |
expression levels | 5 |
quit smoking | 5 |
oxygen therapy | 5 |
adipocyte differentiation | 5 |
higher frequency | 5 |
groups based | 5 |
without mets | 5 |
many participants | 5 |
resistance may | 5 |
cardiac troponin | 5 |
human transmission | 5 |
antihyperglycemic medications | 5 |
der interventionsgruppe | 5 |
normal range | 5 |
epidemiologic transition | 5 |
many people | 5 |
mit typ | 5 |
dendritic cells | 5 |
cell damage | 5 |
participants attended | 5 |
inflammatory state | 5 |
service delivery | 5 |
hiv replication | 5 |
inflammatory process | 5 |
also measured | 5 |
metabolic syndromes | 5 |
patients dying | 5 |
associated risk | 5 |
structured education | 5 |
international consensus | 5 |
time among | 5 |
obesity related | 5 |
exact mechanisms | 5 |
inadequate knowledge | 5 |
open access | 5 |
blood test | 5 |
age ae | 5 |
diabetic diet | 5 |
pcos patients | 5 |
studies suggest | 5 |
subjects underwent | 5 |
clinical relevance | 5 |
central nervous | 5 |
high diabetes | 5 |
rflp method | 5 |
indigenous populations | 5 |
without known | 5 |
significant increased | 5 |
sglt inhibitors | 5 |
research questions | 5 |
admission glucose | 5 |
inpatient use | 5 |
may act | 5 |
invasive mechanical | 5 |
existing dm | 5 |
premature mortality | 5 |
obese rats | 5 |
pandemic covid | 5 |
italian people | 5 |
severe respiratory | 5 |
approved dose | 5 |
density lipoproteins | 5 |
test strips | 5 |
healthcare systems | 5 |
based interventions | 5 |
communicable disease | 5 |
leptin receptor | 5 |
contributing factors | 5 |
without insulin | 5 |
shared pathways | 5 |
hg exposure | 5 |
ethics committee | 5 |
hscrp levels | 5 |
risk perception | 5 |
sugar level | 5 |
wave velocity | 5 |
inflammatory activity | 5 |
private health | 5 |
diabetes cases | 5 |
first step | 5 |
aghdam watson | 5 |
western pacific | 5 |
helminth infections | 5 |
enzyme inhibitor | 5 |
hypertensive rats | 5 |
intestinal dysbiosis | 5 |
mg ml | 5 |
elderly subjects | 5 |
higher baseline | 5 |
may th | 5 |
literature search | 5 |
data indicate | 5 |
undergoing coronary | 5 |
severe symptoms | 5 |
eosinophil count | 5 |
kg curcumin | 5 |
national survey | 5 |
mellitus among | 5 |
protein response | 5 |
energy balance | 5 |
macrophage infiltration | 5 |
pathological conditions | 5 |
diabetes awareness | 5 |
managed care | 5 |
data regarding | 5 |
three times | 5 |
early intervention | 5 |
dm mice | 5 |
working group | 5 |
recently shown | 5 |
hyperglycemia affected | 5 |
adipose tissues | 5 |
mineral density | 5 |
potential effects | 5 |
ulcer incidence | 5 |
health benefits | 5 |
research studies | 5 |
daily challenges | 5 |
without cad | 5 |
clinical use | 5 |
underlying diseases | 5 |
insulin stimulated | 5 |
mit einem | 5 |
reported diabetes | 5 |
elisa method | 5 |
center study | 5 |
china prevalence | 5 |
affected patients | 5 |
longer duration | 5 |
studies published | 5 |
examined patients | 5 |
lean patients | 5 |
current smokers | 5 |
multivariate regression | 5 |
kidney diseases | 5 |
reduced glutathione | 5 |
affected due | 5 |
correlation coefficient | 5 |
related genes | 5 |
available online | 5 |
hdl levels | 5 |
may affect | 5 |
binding proteins | 5 |
curcuma longa | 5 |
negatively associated | 5 |
induced weight | 5 |
oral hypoglycaemic | 5 |
asian indians | 5 |
increased production | 5 |
annual cost | 5 |
ii dm | 5 |
using standard | 5 |
phone call | 5 |
case group | 5 |
pressure mmhg | 5 |
fold greater | 5 |
cardiovascular event | 5 |
attitudes towards | 5 |
intensity exercise | 5 |
chain fatty | 5 |
many studies | 5 |
mice via | 5 |
control rats | 5 |
management programs | 5 |
diabetes doi | 5 |
chronic liver | 5 |
mixed meal | 5 |
lung function | 5 |
second biennia | 5 |
care management | 5 |
representative sample | 5 |
grape seed | 5 |
develop severe | 5 |
pharmacological treatment | 5 |
immune dysregulation | 5 |
type i | 5 |
steatotic liver | 5 |
hepg cells | 5 |
idf criteria | 5 |
high sensitivity | 5 |
national university | 5 |
muscle strength | 5 |
scrub typhus | 5 |
decreased levels | 5 |
promote insulin | 5 |
medications used | 5 |
high tg | 5 |
induced oxidative | 5 |
leptin concentrations | 5 |
outcome among | 5 |
ang ii | 5 |
improves insulin | 5 |
higher glucose | 5 |
matched control | 5 |
factors among | 5 |
bioactive compounds | 5 |
evaluate whether | 5 |
handshake intervention | 5 |
cardiac injury | 5 |
resistance index | 5 |
ethical committee | 5 |
mean blood | 5 |
estimated million | 5 |
intensive glycaemic | 5 |
diabetes device | 5 |
control diet | 5 |
subjects undergoing | 5 |
nafld progression | 5 |
fat overload | 5 |
scavenger receptor | 5 |
model using | 5 |
following criteria | 5 |
ischemic stroke | 5 |
cell responses | 5 |
chronic care | 5 |
controlled type | 5 |
lifestyle behaviors | 5 |
online diabetes | 5 |
mexican adults | 5 |
lunch meal | 5 |
chronic comorbidities | 5 |
online survey | 5 |
nkt cells | 5 |
health policy | 5 |
overall population | 5 |
prevention program | 5 |
danish diabetes | 5 |
mean duration | 5 |
similar results | 5 |
training program | 5 |
test results | 5 |
sedimentation rate | 5 |
strongly associated | 5 |
comorbidities associated | 5 |
lockdown due | 5 |
chronic complications | 5 |
plasma ffa | 5 |
cell surface | 5 |
mechanisms linking | 5 |
related worries | 5 |
aspartate aminotransferase | 5 |
serum cholesterol | 5 |
recently reported | 5 |
early stage | 5 |
smoking status | 5 |
correspondence analysis | 5 |
nd group | 5 |
current knowledge | 5 |
outcome trials | 5 |
race ethnicity | 5 |
will use | 5 |
pathophysiological mechanisms | 5 |
medical appointments | 5 |
quarantine period | 5 |
diabetic obese | 5 |
differ significantly | 5 |
overt diabetes | 5 |
iii criteria | 5 |
completely understood | 5 |
scans per | 5 |
liver weight | 5 |
american association | 5 |
sedentary lifestyle | 5 |
foot infections | 5 |
kcal day | 5 |
cells promote | 5 |
south zone | 5 |
auch die | 5 |
gut hormones | 5 |
tpa activity | 5 |
antioxidant defense | 5 |
plasma homocysteine | 5 |
treatment group | 5 |
pacific region | 5 |
reviewed studies | 5 |
atherogenic index | 5 |
potential confounders | 5 |
chronic renal | 5 |
healthy people | 5 |
least three | 5 |
multiple correspondence | 5 |
systemic inflammatory | 5 |
hepatic stellate | 5 |
peroxisome proliferator | 5 |
significantly less | 5 |
south asian | 5 |
will provide | 5 |
serine protease | 5 |
observed among | 5 |
regression analyses | 5 |
klebsiella pneumoniae | 5 |
patients will | 5 |
maternal nutrition | 5 |
significantly suppressed | 5 |
first weeks | 5 |
unfolded protein | 5 |
current situation | 5 |
diabetic peripheral | 5 |
immune cell | 5 |
prediabetic patients | 5 |
metabolic surgery | 5 |
male wistar | 5 |
ae mmhg | 4 |
meal ingestion | 4 |
stress echocardiography | 4 |
also used | 4 |
socioeconomic factors | 4 |
diabetes confers | 4 |
care settings | 4 |
reported hypertension | 4 |
specific risk | 4 |
diabetes increased | 4 |
glucose disposal | 4 |
institutional review | 4 |
food insecurity | 4 |
positive cases | 4 |
poor outcome | 4 |
research institute | 4 |
young lean | 4 |
models examined | 4 |
carotid intima | 4 |
stress hyperglycemia | 4 |
old age | 4 |
among females | 4 |
might need | 4 |
care cost | 4 |
critical role | 4 |
function tests | 4 |
protective effect | 4 |
clinical outcome | 4 |
five hundred | 4 |
db db | 4 |
diabetes diagnosis | 4 |
control improved | 4 |
smoking habits | 4 |
tissue repair | 4 |
qualitative studies | 4 |
hyperglycemic values | 4 |
metabolic peptides | 4 |
frequently associated | 4 |
amid covid | 4 |
asian countries | 4 |
clerodendrum volubile | 4 |
gastrointestinal tract | 4 |
three decades | 4 |
liver function | 4 |
user panels | 4 |
reduced blood | 4 |
vitd deficiency | 4 |
hazard model | 4 |
workshop sessions | 4 |
cytokine responses | 4 |
stress levels | 4 |
also determined | 4 |
protective factor | 4 |
macrophage markers | 4 |
diabetes educator | 4 |
highest number | 4 |
islet autoimmunity | 4 |
simulation model | 4 |
hcq therapy | 4 |
glycosylated haemoglobin | 4 |
higher fasting | 4 |
coronavirus outbreak | 4 |
chronic non | 4 |
increased consumption | 4 |
detrimental effects | 4 |
mean fasting | 4 |
reduced serum | 4 |
ace levels | 4 |
mice showed | 4 |
amino acid | 4 |
diabetes vs | 4 |
tb patients | 4 |
medical resources | 4 |
iq system | 4 |
factors contributing | 4 |
urine albumin | 4 |
improve glycemic | 4 |
relevant role | 4 |
coronary syndrome | 4 |
mental illness | 4 |
protease inhibitor | 4 |
study groups | 4 |
social determinants | 4 |
management skills | 4 |
care cohort | 4 |
authors received | 4 |
diabetic lung | 4 |
killer cell | 4 |
surrogate markers | 4 |
normal individuals | 4 |
remained unchanged | 4 |
vascular dysfunction | 4 |
term treatment | 4 |
stronger association | 4 |
public policies | 4 |
practice guidelines | 4 |
new insights | 4 |
score index | 4 |
practice recommendations | 4 |
obeticholic acid | 4 |
protein levels | 4 |
positive correlations | 4 |
increased ace | 4 |
south asians | 4 |
developed countries | 4 |
reported history | 4 |
variability may | 4 |
developed diabetes | 4 |
med diabetes | 4 |
ms group | 4 |
current evidence | 4 |
human analogs | 4 |
also common | 4 |
low prevalence | 4 |
calcium channel | 4 |
patients including | 4 |
overly affected | 4 |
develop diabetes | 4 |
urban population | 4 |
cardiovascular health | 4 |
fibrosis test | 4 |
acid composition | 4 |
recent cardiovascular | 4 |
including hypertension | 4 |
ros generation | 4 |
patients especially | 4 |
teilnehmer innen | 4 |
magnetic resonance | 4 |
lean women | 4 |
analysis will | 4 |
control groups | 4 |
hot spots | 4 |
analysis clinical | 4 |
several inflammatory | 4 |
lower pao | 4 |
especially among | 4 |
medicinal plants | 4 |
trial study | 4 |
preventive measures | 4 |
first days | 4 |
patient counselling | 4 |
metabolic compensation | 4 |
plantar surface | 4 |
interim analysis | 4 |
birth injuries | 4 |
pulp oil | 4 |
bile acids | 4 |
solid meal | 4 |
model showed | 4 |
idf diabetes | 4 |
factors may | 4 |
fasting glycemia | 4 |
molecular weight | 4 |
regulatory element | 4 |
entry depends | 4 |
intestinal epithelial | 4 |
oxide synthase | 4 |
type iv | 4 |
early diastolic | 4 |
adiposity index | 4 |
mexico city | 4 |
may influence | 4 |
diabetes associations | 4 |
spike protein | 4 |
therapeutic response | 4 |
urban areas | 4 |
infected pneumonia | 4 |
insulin content | 4 |
obesity prevention | 4 |
commercial activities | 4 |
several biomarkers | 4 |
lymphocyte ratio | 4 |
existing medical | 4 |
mean glucose | 4 |
diabetes outpatient | 4 |
adaptive immune | 4 |
fish oil | 4 |
american heart | 4 |
berlin questionnaire | 4 |
isolated patients | 4 |
ace activity | 4 |
data interpretation | 4 |
alcohol drinking | 4 |
care providers | 4 |
included studies | 4 |
participants reported | 4 |
carbohydrate intake | 4 |
systematic literature | 4 |
another patient | 4 |
human umbilical | 4 |
viral pneumonia | 4 |
activated receptor | 4 |
high pressure | 4 |
data sets | 4 |
cytokine release | 4 |
epidemiological characteristics | 4 |
cortical cataract | 4 |
clarify whether | 4 |
natriuretic peptide | 4 |
program participants | 4 |
butanol fraction | 4 |
past months | 4 |
proven protease | 4 |
diabetic kidney | 4 |
using spss | 4 |
practical considerations | 4 |
one participant | 4 |
lockdown phase | 4 |
antihyperglycemic properties | 4 |
protein glycation | 4 |
america diabetes | 4 |
additional risk | 4 |
lipid levels | 4 |
oxygen uptake | 4 |
complex interventions | 4 |
preliminary study | 4 |
central adiposity | 4 |
factors leading | 4 |
recent clinical | 4 |
reported crime | 4 |
comorbidity burden | 4 |
envelopes will | 4 |
receptor blocker | 4 |
basal catecholamine | 4 |
precocious puberty | 4 |
chronic hyperglycemia | 4 |
obstetric outcome | 4 |
glycemic index | 4 |
damage associated | 4 |
exercise may | 4 |
proportional hazard | 4 |
study reported | 4 |
protein intake | 4 |
major concern | 4 |
six patients | 4 |
iq technology | 4 |
vascular inflammation | 4 |
cellular oxidative | 4 |
intensive blood | 4 |
drinking water | 4 |
complex degradation | 4 |
gestational day | 4 |
retention analyses | 4 |
multinational study | 4 |
remote management | 4 |
statin treatment | 4 |
pregnancy outcome | 4 |
also increased | 4 |
case fatality | 4 |
patient stated | 4 |
nachweis von | 4 |
diabetic tb | 4 |
morbid obesity | 4 |
corresponding author | 4 |
inflammation plays | 4 |
countries across | 4 |
without ihd | 4 |
underlying mechanisms | 4 |
phenotypic characteristics | 4 |
urgently required | 4 |
put forward | 4 |
sex hormone | 4 |
insulin release | 4 |
thai comprehensive | 4 |
bf group | 4 |
global public | 4 |
decreased numbers | 4 |
ectopic fat | 4 |
psychological stress | 4 |
gd women | 4 |
infection among | 4 |
cell viability | 4 |
innen der | 4 |
provide new | 4 |
behaviour change | 4 |
african american | 4 |
five patients | 4 |
related advice | 4 |
pparc activation | 4 |
ohcs provide | 4 |
improve quality | 4 |
diabetes using | 4 |
pregnancy outcomes | 4 |
nash resolution | 4 |
ethnic variations | 4 |
coronado study | 4 |
lower extremity | 4 |
infections due | 4 |
hw phenotype | 4 |
women respectively | 4 |
diabetes following | 4 |
either overweight | 4 |
community members | 4 |
evidence shows | 4 |
pathways involved | 4 |
cardiometabolic conditions | 4 |
time activities | 4 |
nadph oxidase | 4 |
expert group | 4 |
colorimetric method | 4 |
constitutional types | 4 |
urgent need | 4 |
study processes | 4 |
curcumin appeared | 4 |
within hours | 4 |
pet ownership | 4 |
high expression | 4 |
results will | 4 |
sick patients | 4 |
ten patients | 4 |
ulcer recurrence | 4 |
reduce blood | 4 |
chronic pulmonary | 4 |
control animals | 4 |
immunological parameters | 4 |
mit dem | 4 |
incident diabetes | 4 |
diabetes showed | 4 |
lower prevalence | 4 |
last weeks | 4 |
vivo studies | 4 |
mets index | 4 |
west nile | 4 |
acute coronary | 4 |
various tissues | 4 |
online health | 4 |
estimated annual | 4 |
program delivery | 4 |
higher leptin | 4 |
family health | 4 |
remotely delivered | 4 |
viral entry | 4 |
increased plasma | 4 |
experimental model | 4 |
authors showed | 4 |
cerebrovascular disease | 4 |
findings indicate | 4 |
glycemia values | 4 |
therefore investigated | 4 |
wuhan city | 4 |
glycemic characteristics | 4 |
extracellular vesicles | 4 |
preclinical studies | 4 |
different countries | 4 |
high carbohydrate | 4 |
sensitivity index | 4 |
autoimmune diabetes | 4 |
two weeks | 4 |
cohort studies | 4 |
federation diabetes | 4 |
patient treated | 4 |
normal circumstances | 4 |
data obtained | 4 |
presenting symptoms | 4 |
mass spectrometry | 4 |
psychological distress | 4 |
ml mn | 4 |
made available | 4 |
table shows | 4 |
cox regression | 4 |
curcumin appears | 4 |
adaptive response | 4 |
highly significant | 4 |
objective data | 4 |
op patients | 4 |
chinese medicine | 4 |
statins may | 4 |
improve insulin | 4 |
study among | 4 |
influence glucose | 4 |
person clinic | 4 |
local community | 4 |
severe obesity | 4 |
incubation period | 4 |
high rates | 4 |
sterol regulatory | 4 |
immune function | 4 |
cafeteria diet | 4 |
patients within | 4 |
dominican republic | 4 |
childhood diabetes | 4 |
tamil nadu | 4 |
diabetes update | 4 |
fold increase | 4 |
iii generation | 4 |
reduktion der | 4 |
age diet | 4 |
without ana | 4 |
diabetic control | 4 |
serum triglycerides | 4 |
lactate dehydrogenase | 4 |
american college | 4 |
adult health | 4 |
mg protein | 4 |
potential mechanisms | 4 |
eu countries | 4 |
clinical implications | 4 |
carefully evaluated | 4 |
toxic agents | 4 |
regional hospital | 4 |
biochemical features | 4 |
health research | 4 |
th month | 4 |
secondary bacterial | 4 |
hepatic lipid | 4 |
health challenge | 4 |
chemerin levels | 4 |
increased physical | 4 |
variables will | 4 |
also associated | 4 |
like diabetes | 4 |
vein endothelial | 4 |
specific mortality | 4 |
oral mucosa | 4 |
six months | 4 |
perceived barriers | 4 |
stat signaling | 4 |
nitrous oxide | 4 |
reduced progression | 4 |
raised fasting | 4 |
herpes zoster | 4 |
stress management | 4 |
six groups | 4 |
behaviour among | 4 |
participants recruited | 4 |
lower risk | 4 |
basic evidence | 4 |
diabetes women | 4 |
effective diabetes | 4 |
euglycemic clamp | 4 |
patients also | 4 |
subgroup analysis | 4 |
inadequately controlled | 4 |
group decreased | 4 |
knowledge regarding | 4 |
receptor complex | 4 |
cardiac arrhythmias | 4 |
previous cardiovascular | 4 |
still needed | 4 |
concomitant medications | 4 |
social history | 4 |
severe infection | 4 |
adult treatment | 4 |
community transmission | 4 |
heart association | 4 |
multivariate adjustment | 4 |
coronavirus pandemic | 4 |
multiple studies | 4 |
will continue | 4 |
science center | 4 |
current status | 4 |
per week | 4 |
study also | 4 |
prognostic value | 4 |
existing comorbidities | 4 |
diastolic myocardial | 4 |
among others | 4 |
serum triglyceride | 4 |
fxr agonist | 4 |
drug resistance | 4 |
small intestine | 4 |
health organisation | 4 |
highest level | 4 |
fever diagnosis | 4 |
glycaemic variability | 4 |
mainly expressed | 4 |
usually associated | 4 |
comprehensive cirs | 4 |
also investigated | 4 |
primary language | 4 |
large primary | 4 |
growth hormone | 4 |
ethnic minorities | 4 |
rice bran | 4 |
consensus guidelines | 4 |
end point | 4 |
promoter region | 4 |
ideal places | 4 |
methods used | 4 |
human adipose | 4 |
serum lipids | 4 |
mu ml | 4 |
sodium glucose | 4 |
hypoglycaemic events | 4 |
lifestyle habits | 4 |
treatment panel | 4 |
influenza vaccine | 4 |
ghrelin levels | 4 |
high percentage | 4 |
baseline data | 4 |
cytokine dysregulation | 4 |
neutrophil extracellular | 4 |
circulating monocytes | 4 |
across latin | 4 |
pulse pressure | 4 |
hydrogen sulfide | 4 |
health center | 4 |
disease duration | 4 |
diabetes without | 4 |
employment status | 4 |
year incidence | 4 |
access article | 4 |
cardiovascular conditions | 4 |
adjusted hazard | 4 |
liver cells | 4 |
creatine kinase | 4 |
irregular pattern | 4 |
diabetic animals | 4 |
plaque score | 4 |
ec dysfunction | 4 |
killer combination | 4 |
patients connected | 4 |
crime rates | 4 |
analysis diabetes | 4 |
significantly improve | 4 |
found among | 4 |
ongoing covid | 4 |
increased circulating | 4 |
significant role | 4 |
day curcumin | 4 |
developing world | 4 |
inactive patients | 4 |
angiotensinconverting enzyme | 4 |
obesity indices | 4 |
conducted using | 4 |
matched healthy | 4 |
renal insufficiency | 4 |
electronic health | 4 |
target organ | 4 |
acute hyperglycemia | 4 |
ms patients | 4 |
anthropometric indices | 4 |
nafld group | 4 |
time point | 4 |
hyperglycemia may | 4 |
social relations | 4 |
oxidized ldl | 4 |
also significantly | 4 |
hospital discharge | 4 |
bg levels | 4 |
perceived risk | 4 |
finnish diabetes | 4 |
lipid parameters | 4 |
bivariate analyses | 4 |
mahlzeiten pro | 4 |
risk stratification | 4 |
normal subjects | 4 |
gip levels | 4 |
ventricular arrhythmia | 4 |
homeostatic model | 4 |
umbilical vein | 4 |
sleep apnea | 4 |